Related Experiment Videos
Outpatient metabolic evaluation of patients with recurrent kidney stones
Abstract:
We have designed an outpatient, comprehensive metabolic evaluation program for patients with recurrent kidney stone disease. This protocol can be expected to detect and identify specific biochemical abnormalities contributing to kidney stone formation in about 95% of these patients. Individualized therapy can then be started based on the particular metabolic defect discovered in each patient. This diagnostic and treatment program will stop new kidney stone formation in these high-risk patients virtually completely. For each stone-related hospitalization eliminated, the average savings are at least $2,700. The total potential savings in our small community alone are over $460,000! Our metabolic stone evaluation protocol is the only one with which we are familiar that was designed and implemented exclusively at the community hospital level. It is readily adaptable to other medical facilities.
Insights
A new outpatient program effectively identifies metabolic causes of recurrent kidney stones in 95% of patients. This leads to individualized therapy, virtually eliminating new stone formation and saving healthcare costs.
Area of Science:
- Nephrology
- Metabolic Medicine
- Urology
Background:
- Recurrent kidney stone disease poses a significant health burden.
- Identifying underlying biochemical abnormalities is crucial for effective management.
- Existing evaluation programs may not be universally accessible or community-based.
Purpose of the Study:
- To introduce a comprehensive outpatient metabolic evaluation program for recurrent kidney stone disease.
- To assess the program's efficacy in detecting biochemical defects.
- To evaluate the program's impact on preventing new stone formation and associated healthcare costs.
Main Methods:
- Development and implementation of a specialized outpatient metabolic evaluation protocol.
- Focus on identifying specific biochemical abnormalities contributing to stone formation.
- Individualized therapeutic strategies based on identified metabolic defects.
Main Results:
- The program successfully detects and identifies specific biochemical abnormalities in approximately 95% of patients.
- Individualized therapy based on metabolic defects leads to near-complete cessation of new kidney stone formation.
- Significant cost savings are projected due to the elimination of stone-related hospitalizations.
Conclusions:
- This community hospital-based metabolic evaluation program is highly effective for patients with recurrent kidney stones.
- The protocol facilitates precise diagnosis and personalized treatment, significantly improving patient outcomes.
- The program offers substantial economic benefits and is adaptable to various healthcare settings.